LOADING
Comparing Merck & Company (MRK) and Uber Technologies (UBER) across the Health Care and Industrials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | UBER |
|---|---|---|
| Price | $120.87 | $71.84 |
| Change Today | +0.02% | +0.18% |
| Market Cap | $298.8B | $147.9B |
| P/E Ratio | 16.6 | 15.2 |
| Forward P/E | 23.6 | 21.7 |
| PEG Ratio | 3.68 | 4.51 |
| EPS | $7.28 | $4.73 |
| Revenue Growth (YoY) | 5.0% | 20.1% |
| Profit Margin | 28.1% | 19.3% |
| Return on Equity | 36.9% | 39.9% |
| Dividend Yield | 2.68% | -- |
| Beta | 0.28 | 1.21 |
| 52-Week High | $124.22 | $101.99 |
| 52-Week Low | $70.74 | $60.63 |
| Volume | 6.4M | 12.8M |
Merck & Company is the larger company by market capitalization. Uber Technologies trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.